News – Page 1083 – Endpoints News

FDA, EMA put a star CAR-T from bluebird and Celgene on the VIP list

8 years ago

X4 raises $27M to take Sanofi’s old drug through pivotal trial

8 years ago

Johns Hopkins has $65M to spend on taking their drugs right up to human studies

8 years ago

J&J goes back to Ionis for its second experimental pill for a GI autoimmune disease

8 years ago

You want to charge $1M for that gene therapy? Here’s where you’re wrong

8 years ago

Not your mom’s probiotic: GV-backed Evelo teams up with Mayo Clinic on microbiome drugs

8 years ago

Ultragenyx lands first FDA OK, with another on the horizon in shift to commercial ops

8 years ago

Moderna kicks off mRNA cancer vaccine study; Biotech stocks were checked this month -- but that's a good thing

8 years ago

Alkermes touts equal efficacy of monthly Vivitrol against daily Suboxone

8 years ago

Genentech inks $650M deal with protein degradation pioneer Arvinas

8 years ago

Fatal sepsis attacks blight Acorda’s PhIII, triggering new safety measures and torpedoing shares

8 years ago

$49M round; experienced team; A-list VCs — Inozyme launches with rare disease strategy and a yen for bigger things ...

8 years ago

AstraZeneca’s respiratory group scores FDA OK for a blockbuster severe asthma drug

8 years ago

Sangamo claims a major milestone in gene editing, treating first patient with its zinc finger nuclease tech

8 years ago

Award-winning sepsis project gets $13M and a shot at reopening an R&D avenue as FDA pitches out old gold standard

8 years ago

Mirati bails on lead drug, shifts focus to I/O program

8 years ago

San Diego’s stealthy Odonate surfaces with $173M IPO

8 years ago

ImmusanT scores a $40M round for PhII celiac study, with biotech vet Tom Daniel joining the board

8 years ago

Bayer steps up with $1.55B deal to take a lead role in commercializing Loxo’s cancer drugs

8 years ago

Torque takes tumor tech out of stealth with $25M backing, new CEO

8 years ago

Parker Institute, MD Anderson and Seres developing a microbiome/PD-1/L1 combo; CRISPR-Cas antimicrobial biotech Locus ...

8 years ago

Pfizer CEO Read hands off drug development responsibilities to his hand picked successor

8 years ago

Neurodegeneration upstart Denali outlines $100M IPO for its growing clinical work

8 years ago

Google backs I/O startup Arcus in $107M deal

8 years ago

First page Previous page 1080 1081 108210831084 1085 1086 Next page Last page